PEB - Pacific Edge Ltd

[Balance]

To who...Patients or Urologists (& related so-called Professionals)?

Both.

Dis. I talked to one of PEB's executives last year and PEB was certainly not talking user programs at that time!

[Balance]

I actually like the product and like the marketing strategy of combining the user programs with on the ground relationship building sales staff.
I just think the company is not being up front with investors on how difficult, time consuming and costly it is turning out to be to fully commercialize the product.
But I guess if I am right all will continue to be reveled in the next few sales report....... I just think it is poor form from management to deliberately ramp user programs prospect and continue to fail on converting them to sales. This is not a new thing for the company as some of their user programs where completed in 2013 and led to no sales.

Exactly the same reason why I sold the bulk of my shares in PEB. Directors were very quiet at AGM about actual sales.

[MAC]

It’s 2019, and yes, that $100M is very much quite a humble five year goal given the size of the market at 2,000,000 x 550 = $1.1B in annual revenues, esp given Pacific Edge have the best clinically performing process on offer and a first mover advantage with this type of product.

[MAC]

It’s 2019, and yes, that $100M is very much quite a humble five year goal given the size of the market at 2,000,000 x 550 = $1.1B in annual revenues, esp given Pacific Edge have the best clinically performing process on offer and a first mover advantage with this type of product.

Furthermore, just the presently active user programme with Kaiser Permanente alone has them on track, if not ahead of their commercialisation plan. With 9.5M users and prospectively worth $30M per annum, all Pacific Edge require is just one such user programme roll over each year to meet their goal.

[Minerbarejet]

you surely can't be riding the first mover advantage wave still Mac.
The first mover advantage was taken over 10 years ago by another product and company.
In reality PEB are late to the game that's another reason why commercialization is going so slowly.

Miner rises slowly to his feet, whacks his head and falls down again.

[twotic]

Furthermore, just the presently active user programme with Kaiser Permanente alone has them on track, if not ahead of their commercialisation plan. With 9.5M users and prospectively worth $30M per annum, all Pacific Edge require is just one such user programme roll over each year to meet their goal.

Hi Mac, would you mind explaining to novices like me, how the Kaiser user programme works? The way I read your post, it seems to imply a commercial arrangement whereby PEB will receive payment for the tests conducted under the user programme. Is that the case?

[MAC]

Hi Mac, would you mind explaining to novices like me, how the Kaiser user programme works? The way I read your post, it seems to imply a commercial arrangement whereby PEB will receive payment for the tests conducted under the user programme. Is that the case?

Happy to give it a try Twotic, Hancock’s might like to chip in also, it’s all quite different from the health system in NZ, takes some time to get ones head around it, did me anyway.

Kaiser Permanente as an HMO offer both medical insurance policies to their 9.5M users, and also, they own and operate their own regional medical healthcare facilities.

In NZ we have say Southern Cross with a few facilities beyond what the DHB’s offer, although in the US there is not the governmental DHB system in the background. HMO’s like KP perform both a Southern Cross and a DHB type function if you like.

Kaiser Permanente have their own in house clinicians, including 109 urologists and 700 oncologists, mostly spread across California and some in Colorado, located within 38 of their own hospitals.

So, an adoption of Cxbladder by KP is more than just a sign up with an insurer, rather it represents an adoption of a Cxbladder diagnostic process policy by those clinicians, and probably by further clinicians who service KP members who do not have in house KP clinicians geographically close by, Oregon, Hawaii, Georgia etc.

[skid]

Miner rises slowly to his feet, whacks his head and falls down again.

Miner goes out and buys a safety helmet and then everything's ok--because he knows despite all this noise the sales report is going to be the deciding factor for now.

[skid]

Me thinks you can expect the same with the commentary from the coming results.
I would like to see 1000 -2000 US sales this report but foresee 400-500 US sales which will be further confirmation that things are going way slower than planned.
Share price will adjust accordingly.

So do we have any other sales estimates that would indicate they are on track or not. Hancock? (Or Mac,although from your posts you dont seem to place as much importance on sales for this report) Im not sure the market will buy that though.

So for all you well informed and novices out there --What sales figure should we be looking for? (to prove they are on track)

[twotic]

Happy to give it a try Twotic, Hancock’s might like to chip in also, it’s all quite different from the health system in NZ, takes some time to get ones head around it, did me anyway.

Kaiser Permanente as an HMO offer both medical insurance policies to their 9.5M users, and also, they own and operate their own regional medical healthcare facilities.

In NZ we have say Southern Cross with a few facilities beyond what the DHB’s offer, although in the US there is not the governmental DHB system in the background. HMO’s like KP perform both a Southern Cross and a DHB type function if you like.

Kaiser Permanente have their own in house clinicians, including 109 urologists and 700 oncologists, mostly spread across California and some in Colorado, located within 38 of their own hospitals.

So, an adoption of Cxbladder by KP is more than just a sign up with an insurer, rather it represents an adoption of a Cxbladder diagnostic process policy by those clinicians, and probably by further clinicians who service KP members who do not have in house KP clinicians geographically close by, Oregon, Hawaii, Georgia etc.

OK, thanks for that. So with respect to the KP user programme, would it be accurate to say PEB will not directly generate any income from it, rather it could be a subsequent commercial arrangement with KP, should results from the user programme warrant it, that would subsequently generate income?

By the way, I have been chatting with minor. There may be a few tid bits from our conversation that may interest you. Feel free to PM him or me if you like.